Management ChangeMay 11, 2026, 05:12 PM
BioHarvest Appoints Co-Founder Dr. Zaki Rakib as CEO; Ilan Sobel Joins Board
AI Summary
BioHarvest Sciences announced a strategic leadership transition to enhance its "two-lens strategy" for its direct-to-consumer (D2C) and Contract Development and Manufacturing Organization (CDMO) businesses. Dr. Zaki Rakib, Co-Founder and Executive Chairman, has assumed the role of Chief Executive Officer, consolidating leadership of R&D, Manufacturing, and Operations in the CDMO division. Ilan Sobel, who served as CEO since 2020, has transitioned to the Company's Board of Directors, where he will focus on the D2C business. The Board expressed appreciation for Mr. Sobel's contributions, including growing the company to approximately $35 million in revenue in fiscal year 2025.
Key Highlights
- Dr. Zaki Rakib, Co-Founder and Executive Chairman, appointed Chief Executive Officer.
- Dr. Rakib will consolidate R&D, Manufacturing, and Operations in the CDMO division.
- Ilan Sobel transitioned from CEO to the Board of Directors.
- Mr. Sobel will focus on advancing the D2C business on the Board.
- Dr. Rakib has over 35 years of executive leadership experience.
- Dr. Rakib previously scaled Terayon Communication Systems to $380M revenue and $7B market cap.
- Mr. Sobel led BioHarvest from pre-revenue to approximately $35 million in fiscal year 2025.